We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+6.02%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$2.37B
AUM Growth
+$453M
Cap. Flow
+$337M
Cap. Flow %
14.21%
Top 10 Hldgs %
52.25%
Holding
309
New
28
Increased
109
Reduced
121
Closed
12

Top Buys

Rank Stock Value
1
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$147M
2
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$76.7M
3
SUB icon
iShares Short-Term National Muni Bond ETF
SUB
+$65.1M
4
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$57.7M
5
IGSB icon
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
+$35.6M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$75M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$20.3M
3
TER icon
Teradyne
TER
+$10.5M
4
CIEN icon
Ciena
CIEN
+$8.25M
5
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$6.7M

Sector Composition

Rank Sector Weight
1 Technology 10.08%
2 Healthcare 7.83%
3 Financials 5.02%
4 Industrials 4.83%
5 Consumer Discretionary 2.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INCY icon
26
Incyte
INCY
$24.9B
$15.7M 0.66%
195,415
-7,348
-4% -$562K
ACN icon
27
Accenture
ACN
$99.9B
$15.6M 0.66%
58,360
+2,576
+5% +$713K
ABBV icon
28
AbbVie
ABBV
$455B
$14.8M 0.62%
91,384
+3,096
+4% +$475K
JNJ icon
29
Johnson & Johnson
JNJ
$617B
$14.6M 0.62%
82,684
+4,960
+6% +$856K
GOOGL icon
30
Alphabet (Google) Class A
GOOGL
$4.08T
$14.6M 0.61%
164,911
+4,329
+3% +$411K
TROW icon
31
T. Rowe Price
TROW
$25.6B
$14.5M 0.61%
132,968
-12,786
-9% -$1.45M
INTC icon
32
Intel
INTC
$460B
$13.9M 0.58%
524,134
-55,979
-10% -$1.55M
QCOM icon
33
Qualcomm
QCOM
$160B
$13.8M 0.58%
125,248
-474
-0.4% -$55.5K
EOG icon
34
EOG Resources
EOG
$77.5B
$13.6M 0.58%
105,334
+3,968
+4% +$528K
COST icon
35
Costco
COST
$423B
$13.6M 0.57%
29,733
-137
-0.5% -$66.9K
RHI icon
36
Robert Half
RHI
$3.81B
$13.3M 0.56%
180,360
+9,745
+6% +$743K
V icon
37
Visa
V
$673B
$13M 0.55%
62,732
+96
+0.2% +$19.4K
NVS icon
38
Novartis
NVS
$301B
$12.9M 0.55%
142,691
+45
+0% +$3.79K
SYY icon
39
Sysco
SYY
$40.6B
$12.9M 0.54%
168,360
-2,078
-1% -$168K
BIIB icon
40
Biogen
BIIB
$30.7B
$12.7M 0.54%
46,035
-686
-1% -$194K
UNH icon
41
UnitedHealth
UNH
$383B
$12.3M 0.52%
23,273
+41
+0.2% +$21.7K
MDT icon
42
Medtronic
MDT
$110B
$12M 0.51%
154,770
-4,798
-3% -$389K
CTAS icon
43
Cintas
CTAS
$82.7B
$11.6M 0.49%
103,020
-416
-0.4% -$45K
SLB icon
44
SLB Ltd
SLB
$72.6B
$11.4M 0.48%
213,626
-1,603
-0.7% -$79.8K
JPM icon
45
JPMorgan Chase
JPM
$933B
$11.3M 0.48%
84,590
+6,567
+8% +$832K
EA icon
46
Electronic Arts
EA
$52.9B
$10.9M 0.46%
89,609
-1,318
-1% -$166K
LULU icon
47
lululemon athletica
LULU
$13.6B
$10.9M 0.46%
34,102
+25
+0.1% +$8.22K
NVO
48
Novo Nordisk
NVO
$228B
$10.8M 0.46%
159,324
+2,340
+1% +$137K
AMAT icon
49
Applied Materials
AMAT
$398B
$10.4M 0.44%
106,731
+103,538
+3,243% +$9.93M
IJR icon
50
iShares Core S&P Small-Cap ETF
IJR
$110B
$10.2M 0.43%
107,912
-10,866
-9% -$1.04M
1
2
3 4 5

Similar funds

DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
AG
AlTi Global New York $4.6B AUM 22.54% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return

Grimes & Company's Q4 2022 Portfolio in Review

As of Q4 2022, Grimes & Company held 309 positions worth $2.37B, up 24% from $1.92B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Grimes & Company deployed $337M of net new capital in Q4 2022, opening 28 new positions and adding to 109 existing holdings. Its largest new stake was Vanguard Short-Term Corporate Bond ETF: 1,968,274 shares worth $148M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $75M trimmed.

  • Grimes & Company's largest Q4 2022 buy was Vanguard Short-Term Corporate Bond ETF: 1,968,274 shares worth $148M.
  • Grimes & Company added most to iShares 0-1 Year Treasury Bond ETF in Q4 2022, an estimated $76.7M increase.
  • Grimes & Company's biggest Q4 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $75M.
  • Grimes & Company fully exited First Trust Enhanced Short Maturity ETF in Q4 2022, selling an estimated $2.63M.
  • Grimes & Company's ten largest holdings make up 52% of its $2.37B portfolio in Q4 2022.
  • Grimes & Company opened 28 new positions and closed 12 in Q4 2022.
  • Grimes & Company's portfolio value rose 24% quarter-over-quarter to $2.37B.

Based on Grimes & Company's 13F filing for Q4 2022, filed 25 Jan 2023.